COMMUNIQUÉS West-GlobeNewswire
-
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 41 - 2025
15/10/2025 -
Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic
15/10/2025 -
Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”
15/10/2025 -
Ketabon Presents New Data Showing Antidepressant Effects of Oral Ketamine (KET01) Are Independent of Dissociation
15/10/2025 -
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
15/10/2025 -
Canada’s Largest Family Medicine Gathering Comes to Winnipeg This November
15/10/2025 -
Le plus grand rassemblement de médecins de famille au pays posera ses valises à Winnipeg en novembre
15/10/2025 -
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
15/10/2025 -
Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
15/10/2025 -
Noom Introduces “Mindful Art Break” — A Weekly Practice Designed to Spark Awe, Relieve Stress, and Boost Psychological Wellbeing
15/10/2025 -
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
15/10/2025 -
Biomerica Reports First Quarter Fiscal 2026 Financial Results
15/10/2025 -
Quercis Pharma and Thomas Lines Nominated for Prestigious Prix Galien USA “Best Startup” Award
15/10/2025 -
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
15/10/2025 -
Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit
15/10/2025 -
Mainz Biomed to Attend 2025 Maxim Growth Summit
15/10/2025 -
DETERA Therapeutics Wins the Ipsen Golden Ticket 2025
15/10/2025 -
Olympia Pharmaceuticals and Wesley Pharmaceuticals Co-Founder Naomi Loomis Establishes $10,000 Scholarship for The Ohio State University’s College of Pharmacy
15/10/2025 -
PathAI Expands AISight Dx with v2.17 Release: Presentation Queues for Tumor Boards, Consult Workflows and Voice-Enabled Reporting
15/10/2025
Pages